Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

Urinary tract infectious disease

A bacterial infectious process affecting any part of the urinary tract, most commonly the bladder and the urethra. Symptoms include urinary urgency and frequency, burning sensation during urination, lower abdominal discomfort, and cloudy urine. [from NCI]

MedGen UID:
52943
Concept ID:
C0042029
Disease or Syndrome
2.

Diabetes mellitus

A group of abnormalities characterized by hyperglycemia and glucose intolerance. [from HPO]

MedGen UID:
8350
Concept ID:
C0011849
Disease or Syndrome
3.

Bacteriuria

The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection. [from MeSH]

MedGen UID:
491
Concept ID:
C0004659
Disease or Syndrome
4.

symptomatic

MedGen UID:
880232
Concept ID:
CN235625
Finding
5.

Infections

MedGen UID:
678472
Concept ID:
C0851162
Disease or Syndrome
6.

Asymptomatic bacteriuria

MedGen UID:
537418
Concept ID:
C0262380
Disease or Syndrome
7.

Diabetes mellitus

A group of abnormalities characterized by hyperglycemia and glucose intolerance. [from HPO]

MedGen UID:
504609
Concept ID:
CN000766
Finding
8.

Recurrent urinary tract infections

Repeated infections of the urinary tract. [from HPO]

MedGen UID:
500878
Concept ID:
CN000011
Finding
9.

Asymptomatic

Without clinical signs or indications that raise the possibility of a particular disorder or dysfunction. [from NCI]

MedGen UID:
65413
Concept ID:
C0231221
Finding
10.

Ulinastatin

A multivalent Kunitz-type serine protease inhibitor derived from human urine, with potential protective, anti-fibrinolytic and anticoagulant activities. Upon administration, ulinastatin (or urinary trypsinogen inhibitor) inhibits the activities of a variety of enzymes, including trypsin, chymotrypsin, thrombin, kallikrein, plasmin, elastase, cathepsin, lipase, hyaluronidase, factors IXa, Xa, XIa, and XlIa, and polymorphonuclear leukocyte elastase. In addition, ulinastatin inhibits the excessive release of proinflammatory mediators, such as tumor necrosis factor-alpha, interleukin-6 and -8, and chemokines. Altogether, this agent may improve the microcirculation, perfusion and function of tissues and may protect organ injury. [from NCI]

MedGen UID:
36073
Concept ID:
C0077906
Amino Acid, Peptide, or Protein; Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center